
Pentec Health’s Specialty Care Nurse Fellowship Granted Accreditation With Distinction By The American Nurses Credentialing Center
October 19, 2023 | Press, Awards
Pentec Health, Inc.’s Specialty Care Nurse Fellowship has been granted Accreditation with Distinction, the highest recognition bestowed by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation in Practice Transition Programs.
Pentec Health and Lobe Sciences Announce Exclusive Distribution Agreement, Initial Availability of Altemia, First U.S. Medical Food For People with Sickle Cell Disease
September 20, 2023 | Press
Pentec Health, Inc. and Lobe Sciences Ltd. are pleased to announce an exclusive U.S. distribution agreement and the initial availability of Altemia™ – the first medical food in the U.S. designed specifically for children and adults with sickle cell disease (SCD).
Americans with Metabolic Diseases Have Access To Firstplay Dietary Foods and Promin Low-Protein Foods via Exclusive Distribution Agreement With Pentec Health, ZOIA Pharma
August 18, 2023 | Press
People living in the U.S. with metabolic disorders now have access to Firstplay Dietary Foods and Promin low-protein food products through an exclusive U.S. distribution agreement with Pentec Health and ZOIA Pharma.
Pentec Health’s Acquisition of ZOIA Pharma Provides People With Phenylketonuria (PKU) Access to the PKU GOLIKE® Family of Medical Food Products
July 18, 2023 | Press
ZOIA Pharma, the only medical food provider in the U.S. focused exclusively on supporting the rare disease community, has been acquired by Pentec Health, Inc. (Pentec), ensuring more people with rare conditions have improved access to a complete range of medical foods.
Market Leader Pentec Health Transforming as Complex Care Provider, Expanding Into Adjacent Underserved Clinical Nutrition, Specialty Care Markets
June 21, 2023 | Press
Pentec Health, Inc., a leading provider of healthcare services for complex care challenges, is transforming into a Complex Care Provider to reflect the expansion of its market-leading expertise into adjacent emerging and underserved areas of clinical nutrition and specialty care.
Pentec Health Names Matthew Deans President and Chief Executive Officer, Continuing Focus on Strategic Growth and Expansion of Patient Care Services and Products to Address Complex Care Needs
April 10, 2023 | Press, News and Events
Pentec Health Inc., a nationwide leader in providing patient-specific compounded sterile medications and complex in-home clinical services, announced today that Matthew Deans would lead the company as President and Chief Executive Officer, effective April 10.
Pentec Health Inc., Will Be Featured on a Special Episode of “The Balancing Act®” Airing on Lifetime®
February 23, 2023 | Press, News and Events
The episode will highlight the benefits of Proplete® Intradialytic Parenteral Nutrition (IDPN) and Intraperitoneal Nutrition (IPN) protein therapies for malnourished hemodialysis and peritoneal dialysis patients.
Transitional Care Units in Dialysis
Despite continuous efforts to educate on CKD, many patients starting dialysis in the United States still are not aware of, or understand, dialysis.
Pentec Health welcomes Eric C. Mollman as Chief Financial Officer
March 21, 2022 | Press
Pentec Health Inc., a nationwide leader in providing patient-specific compounded sterile medications and complex in-home clinical services, welcomes Eric C. Mollman, Chief Financial Officer.
Pentec Health Inc., welcomes Matthew L. Deans as Chief Strategy Officer and Executive Vice President of the Renal Division
January 27, 2022 | Press
Pentec Health Inc., a nationwide leader in providing patient-specific compounded sterile medications and complex in-home clinical services, welcomes Matthew L. Deans as Chief Strategy Officer and Executive Vice President of the Renal Division.

Proudly Quality Accredited
National Quality Approval
The Joint Commission

Accredited Practice Transition
Program With Distinction
American Nurses Credentialing Center
By using this website you accept our privacy policy. Choose the browser data you consent to allow: